FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Phoenix Life Sciences International Limited Stock AnalysisComprehensive stock analysis for Phoenix Life Sciences International Limited (PLSI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPLSI
PLSI
Phoenix Life Sciences International Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PLSI
Home🔹Stocks🔹Phoenix Life Sciences International Limited

Phoenix Life Sciences International Limited

PLSI•OTC

Phoenix Life Sciences International Limited

PLSI•OTC
Market cap
$365.91K
Sentiment

Your view on PLSI

Mkt Cap
$365.91K
Sentiment
Your view
PLSI
Phoenix Life Sciences International Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PLSI
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Phoenix Life Sciences International Limited

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Willis Victory
Headquarters
4262 Blue Diamond Road, Las Vegas, NV, US
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Willis Victory
Headquarters
4262 Blue Diamond Road, Las Vegas, NV, US
Description

Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. The company focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancers, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. It offers oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams. The company was formerly known as Stem Bioscience, Inc. and changed its name to Phoenix Life Sciences International Limited in May 2018. Phoenix Life Sciences International Limited was incorporated in 2009 and is headquartered in Las Vegas Nevada.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News